IQVIA Holdings Inc. vs Eli Lilly & Co.
IQV vs LLY — side-by-side comparison from reported financials. IQV leads 2, LLY leads 9 of 11 comparable metrics.
IQVIA Holdings Inc.
IQV · Healthcare
$259.88+0.39%Strained
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | IQV | LLY |
|---|---|---|
| Price | $259.88 | $1 177.20 |
| Market cap | $42.8B | $1.05T |
| Revenue (TTM) | $17.0B | $79.7B |
| Revenue growth | +4.2% | +31.7% |
| Net margin | 8.1% | 33.5% |
| Free cash flow | $2.18B | $18.2B |
| Net cash (debt) | ($11.7B) | ($35.2B) |
| 1-year price return | +28.0% | +37.6% |
| P/E | 31.1 | 41.6 |
| P/E vs own history (cheap-side %) | 56% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | 22% | 93% |
| Altman Z-score | 1.78 | 7.10 |
| CV checks passed | 8 of 10 | 11 of 10 |
| Employees | 94,000 | 50,000 |
Full résumé-style profiles: IQV CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.